x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

35:57

Improving the alpha-mannosidosis patient journey

touchPODCAST ·

2023/02/23

touchEXPERT OPINIONS for touchRESPIRATORY Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. The expert: Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Chiesi USA,

en

35:58

Improving the alpha-mannosidosis patient journey

touchPODCAST ·

2023/02/23

touchEXPERT OPINIONS for touchNEUROLOGY Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. The expert: Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Chiesi USA, Inc

en

14:54

HER2 testing in colorectal cancer

touchPODCAST ·

2023/02/23

touchMDT for touchONCOLOGY A medical oncologist and a pathologist discuss HER2 testing in patients with colorectal cancer, including when and how to test, and the interpretation of test results. The multidisciplinary team: Medical oncologist: Prof. Andrea Sartore-Bianchi, Niguarda Cancer Center, Milan, Italy Pathologist: Dr Evgeny Yakirevich, Rhode Island Hospital, Providence, RI, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Seagen

en

10:00

Managing treatment side effects in HER2-positive...

touchPODCAST ·

2023/02/23

touchMDT for touchONCOLOGY A medical oncologist, advanced practice nurse and patient advocate discuss possible side effects of colorectal cancer treatments and how they can be managed in the multidisciplinary team setting. The multidisciplinary team: Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA Patient advocate: Mr Scott Wilson, Denver, CO, USA This touchPODCAST is for HCPs

en

13:41

Supporting patients with HER2-positive colorectal cancer

touchPODCAST ·

2023/02/23

touchMDT for touchONCOLOGY A medical oncologist, advanced practice nurse and patient advocate share their views on how the multidisciplinary team can support patients with HER2-positive colorectal cancer. The multidisciplinary team: Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA Patient advocate: Mr Scott Wilson, Denver, CO, USA This touchPODCAST is for HCPs only. This activity

en

13:03

Utilizing HER2-targeted treatments in colorectal cancer

touchPODCAST ·

2023/02/23

touchMDT for touchONCOLOGY Two medical oncologists discuss the latest clinical trial data for HER2-targeted treatments in colorectal cancer (CRC), how they utilize these agents in clinical practice, and what the future holds for HER2-targeting in CRC. The multidisciplinary team: Medical oncologists: Dr Kristen Ciombor, Nashville, TN, USA and Prof. Andrea Sartore-Bianchi, Milan, Italy This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Seagen

en

32:31

Navigating the complexities of the NSCLC treatment...

touchPODCAST ·

2023/02/20

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC. The experts: Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland Dr Rebecca Heist, Massachusetts General

en

34:32

Higher-risk MDS: An update on emerging novel agents

touchPODCAST ·

2023/02/14

touchTALKS for touchONCOLOGY Listen to a leading expert in higher-risk myelodysplastic neoplasms (HR-MDS) discuss the impact that emerging treatment options may have on clinical practice. Dr David Sallman covers the latest updates to the classification of HR-MDS, the mode of action of emerging therapeutic agents and the most recent clinical evidence on their efficacy and safety. The expert: Dr David Sallman, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA This touchPODCAST is for

en

13:47

Supporting families to optimize outcomes

touchPODCAST ·

2023/02/13

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma. The multidisciplinary team Paediatric immunologist: Dr Wanda Phipatanakul Primary care physician: Dr Ioanna Tsiligianni Specialist asthma nurse: Ms Viv Marsh Patient advocate: Ms Monique Cooper This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Sanofi

en

13:48

Supporting families to optimize outcomes

touchPODCAST ·

2023/02/13

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma. The multidisciplinary team: Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK Patient advocate: Ms Monique Cooper,

en

13:15

The role of the MDT in managing paediatric severe...

touchPODCAST ·

2023/02/13

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma. The multidisciplinary team Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West

en

13:15

The role of the MDT in managing paediatric severe...

touchPODCAST ·

2023/02/13

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma. The multidisciplinary team: Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West

en

13:55

The use of biologics in children with severe type 2...

touchPODCAST ·

2023/02/13

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment. The multidisciplinary team: Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Patient advocate: Ms Monique Cooper, Miami, FL, USA This touchPODCAST

en

13:55

The use of biologics in children with severe type 2...

touchPODCAST ·

2023/02/13

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment. The multidisciplinary team: Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Patient advocate: Ms Monique Cooper, Miami, FL, USA This touchPODCAST

en

14:50

Accurately diagnosing severe type 2 asthma in children

touchPODCAST ·

2023/02/13

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions. The multidisciplinary team: Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece Patient advocate:

en

14:50

Accurately diagnosing severe type 2 asthma in children

touchPODCAST ·

2023/02/13

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team and a patient advocate discuss the diagnosis of severe asthma in children, and the use of biomarkers to support decisions. The multidisciplinary team: Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece Patient advocate: Ms

en

12:51

MDT perspectives on the current and emerging...

touchPODCAST ·

2023/01/19

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting. The multidisciplinary team: Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA This

en

14:18

MDT perspectives on managing side effects associated...

touchPODCAST ·

2023/01/19

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life The multidisciplinary team: Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA,

en

15:06

MDT perspectives on tailoring second-line treatment...

touchPODCAST ·

2023/01/19

Listen to key experts from a multidisciplinary team discuss how side effects of SCLC treatment and patient performance status impact treatment selection and prognosis, and the potential for molecular classification to determine future treatment options The multidisciplinary team Medical oncologist: Dr Barbara Melosky, British Columbia, Canada Pulmonologist: Dr Christine Argento, Maryland, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant

en

14:18

MDT perspectives on managing side effects associated...

touchPODCAST ·

2023/01/19

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the management strategies for patients with relapsed SCLC experiencing treatment side effects and consider how to balance clinical effectiveness with patient quality of life The multidisciplinary team: Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada Oncology nurse practitioner: Dr Victoria Sherry, Abramson Cancer Center, Hospital of the University of Pennsylvania, PA,

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter